CA9 and neoplasm: ADCC in SK-RC-09 cells:25:1 effector to target cells: 25% for G36 and G119; 15–20% for G10, G37, and G39;50:1 effector to target cells: 45% for G10, G36, G37, and G119; 30% for G39In vivo tumor weight (Day 29)/volume (Day 28)reduction (SK-RC-59 CAIX+ cells):85%/75% for G37, G119, mG37, and mG119